Atlas Trials

Interferon and Octreotide to Treat Zollinger-Ellison Syndrome and Advanced Non-B Islet Cell Cancer

Clinical trial NCT00001228 · COMPLETED

Trial details

NCT number
NCT00001228
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Islet Cell AdenomaZollinger Ellison Syndrome
Start date
1988-10-25
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.